Literature DB >> 12351487

Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing.

David J Margolis1, Lynne Allen-Taylor, Ole Hoffstad, Jesse A Berlin.   

Abstract

OBJECTIVE: The goal of this study was to evaluate whether simple risk factors can be identified that successfully characterize who will heal and who will not heal among patients who have received standard therapy for diabetic neuropathic foot ulcers. RESEARCH DESIGN AND METHODS: For this cohort study, we evaluated >31,000 individuals with a diabetic neuropathic foot ulcer seen in the Curative Health Services System. Using multivariate logistic regression, we evaluated the association between wound size, wound duration, wound grade, and other variables and their effect on whether a patient would heal by the 20th week of care.
RESULTS: We demonstrated that wound size, wound duration, and wound grade are all significantly associated with the likelihood of a wound healing by the 20th week of care. In addition, we noted that these associations were not significantly affected by the treating wound care center, whether the unit of analysis was one wound on a patient or all of their wounds, or current adjuvant therapies.
CONCLUSIONS: We have shown that three easy-to-measure risk factors are associated with a wound healing. These results should help clinicians understand the likelihood that a wound will heal and help those conducting clinical investigations to design better trials.

Entities:  

Mesh:

Year:  2002        PMID: 12351487     DOI: 10.2337/diacare.25.10.1835

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  51 in total

1.  Stratification of foot risk predicts the incidence of new foot disease, but do we yet know that the adoption of routine screening reduces it?

Authors:  W J Jeffcoate
Journal:  Diabetologia       Date:  2011-02-18       Impact factor: 10.122

2.  Comparative effectiveness of the SNaP™ Wound Care System.

Authors:  David W Hutton; Peter Sheehan
Journal:  Int Wound J       Date:  2011-03-08       Impact factor: 3.315

Review 3.  Care of chronic wounds in palliative care and end-of-life patients.

Authors:  Christine A Chrisman
Journal:  Int Wound J       Date:  2010-05-28       Impact factor: 3.315

4.  A review of the Eurodiale studies: what lessons for diabetic foot care?

Authors:  Simeen Akhtar; Nicolaas Schaper; Jan Apelqvist; Edward Jude
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

5.  Variants in genes belonging to the fibroblast growth factor family are associated with lower extremity amputation in non-Hispanic whites: Findings from the chronic renal insufficiency cohort study.

Authors:  Jayanta Gupta; Nandita Mitra; Raymond R Townsend; Michael Fischer; Jeffrey R Schelling; David J Margolis
Journal:  Wound Repair Regen       Date:  2016-06-20       Impact factor: 3.617

6.  Combined Effects of Drugs and Plasticizers on the Properties of Drug Delivery Films.

Authors:  Cheryl L Jennings; Thomas D Dziubla; David A Puleo
Journal:  J Bioact Compat Polym       Date:  2016-06-21       Impact factor: 1.756

7.  Variation in the recorded incidence of amputation of the lower limb in England.

Authors:  N Holman; R J Young; W J Jeffcoate
Journal:  Diabetologia       Date:  2012-03-08       Impact factor: 10.122

8.  Risk factors for amputation in patients with diabetic foot infection: a prospective study.

Authors:  Serhat Uysal; Bilgin Arda; Meltem I Taşbakan; Şevki Çetinkalp; Ilgın Y Şimşir; Anıl M Öztürk; Ayşe Uysal; İlgen Ertam
Journal:  Int Wound J       Date:  2017-07-19       Impact factor: 3.315

Review 9.  Platelet-rich plasma: support for its use in wound healing.

Authors:  Kathleen M Lacci; Alan Dardik
Journal:  Yale J Biol Med       Date:  2010-03

10.  A classification of diabetic foot infections using ICD-9-CM codes: application to a large computerized medical database.

Authors:  Benjamin G Fincke; Donald R Miller; Robin Turpin
Journal:  BMC Health Serv Res       Date:  2010-07-06       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.